Arca Biopharma reported $-5680000 in Operating Profit for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Amgen AMGN:US $ 2176M 324M
Arca Biopharma ABIO:US $ -5680000 1.58M
Biogen BIIB:US $ -59.1M 669.8M
Brainstorm Cell Therapeutics BCLI:US $ -5475000 737K
Bristol Myers Squibb BMY:US $ 2590M 37M
Capricor Therapeutics CAPR:US $ -7.83M 1.44M
Cytokinetics CYTK:US $ -10.87M 69.68M
Cytrx CYTR:US -1294610 7.73M
Daiichi Sankyo 4568:JP Y 34382M 85129M
Gilead Sciences GILD:US $ 2029M 1832M
GlaxoSmithKline GSK:LN 1.08B 1.72B
Laboratory Of America LH:US $ 525.9M 162M
Otsuka Holdings 4578:JP Y 46397M 25648M
Pfizer PFE:US $ 12102M 2229M
United Therapeutics UTHR:US $ 201.8M 84.5M